- Home
- Publications
- Publication Search
- Publication Details
Title
Current Management of Primary Immune Thrombocytopenia
Authors
Keywords
Eltrombopag, Immune thrombocytopenia, ITP, Management, Romiplostim, Second-line therapy, Sustained responses, TPO receptor agonists
Journal
ADVANCES IN THERAPY
Volume 32, Issue 10, Pages 875-887
Publisher
Springer Nature
Online
2015-10-26
DOI
10.1007/s12325-015-0251-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
- (2015) Tomás José González-López et al. AMERICAN JOURNAL OF HEMATOLOGY
- Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
- (2015) Adrian Newland et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults
- (2015) Libor Červinek et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Waleed Ghanima et al. LANCET
- A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia
- (2014) J. B. Bussel et al. BLOOD
- The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
- (2014) Matthieu Mahévas et al. BRITISH JOURNAL OF HAEMATOLOGY
- T cell immune abnormalities in immune thrombocytopenia
- (2014) Xuebin Ji et al. Journal of Hematology & Oncology
- Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
- (2013) David J. Kuter et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists
- (2013) Bahareh Ghadaki et al. TRANSFUSION
- Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
- (2012) M. N. Saleh et al. BLOOD
- The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia
- (2011) Manel Roca et al. AMERICAN JOURNAL OF HEMATOLOGY
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
- (2011) C. Neunert et al. BLOOD
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial
- (2011) Yukari Shirasugi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Evidence-Based Mini-Review: Is Indium-Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in Patients With Chronic Immune Thrombocytopenia?
- (2011) A. Cuker et al. Hematology-American Society of Hematology Education Program
- Autologous 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry
- (2010) Ameet Sarpatwari et al. BRITISH JOURNAL OF HAEMATOLOGY
- Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
- (2010) Gregory Cheng et al. LANCET
- International consensus report on the investigation and management of primary immune thrombocytopenia
- (2009) D. Provan et al. BLOOD
- Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database
- (2009) W. Marieke Schoonen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Characteristics of immune thrombocytopenic purpura: a guide for clinical practice
- (2009) Drew Provan EUROPEAN JOURNAL OF HAEMATOLOGY
- Treatment practices in adults with chronic immune thrombocytopenia â a European perspective
- (2009) Francesco Rodeghiero et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Intravenous Immunoglobulin and Anti-RhD Therapy in the Management of Immune Thrombocytopenia
- (2009) Nichola Cooper HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
- (2009) James B Bussel et al. LANCET
- Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology
- (2008) Yataro Yoshida ANNALS OF HEMATOLOGY
- Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
- (2008) R. Stasi et al. BLOOD
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
- (2008) David J Kuter et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started